nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—CYP1B1—Mitoxantrone—multiple sclerosis	0.0599	0.0914	CbGbCtD
Tamoxifen—CYP19A1—Betamethasone—multiple sclerosis	0.0433	0.0661	CbGbCtD
Tamoxifen—CYP2E1—Fingolimod—multiple sclerosis	0.0432	0.0659	CbGbCtD
Tamoxifen—ABCG2—Cladribine—multiple sclerosis	0.039	0.0596	CbGbCtD
Tamoxifen—ABCB11—Dexamethasone—multiple sclerosis	0.031	0.0474	CbGbCtD
Tamoxifen—CYP1B1—Dexamethasone—multiple sclerosis	0.031	0.0474	CbGbCtD
Tamoxifen—ABCG2—Mitoxantrone—multiple sclerosis	0.0285	0.0435	CbGbCtD
Tamoxifen—CYP2A6—Prednisolone—multiple sclerosis	0.027	0.0413	CbGbCtD
Tamoxifen—CYP19A1—Dexamethasone—multiple sclerosis	0.0252	0.0384	CbGbCtD
Tamoxifen—CYP2D6—Fingolimod—multiple sclerosis	0.0206	0.0314	CbGbCtD
Tamoxifen—CYP2E1—Mitoxantrone—multiple sclerosis	0.0203	0.031	CbGbCtD
Tamoxifen—ABCC2—Dexamethasone—multiple sclerosis	0.0163	0.0249	CbGbCtD
Tamoxifen—CYP2A6—Dexamethasone—multiple sclerosis	0.0159	0.0243	CbGbCtD
Tamoxifen—ABCG2—Dexamethasone—multiple sclerosis	0.0148	0.0225	CbGbCtD
Tamoxifen—ABCB1—Methylprednisolone—multiple sclerosis	0.0141	0.0215	CbGbCtD
Tamoxifen—CYP1A1—Dexamethasone—multiple sclerosis	0.0136	0.0208	CbGbCtD
Tamoxifen—ABCC2—Methotrexate—multiple sclerosis	0.0131	0.02	CbGbCtD
Tamoxifen—CYP3A4—Fingolimod—multiple sclerosis	0.0131	0.02	CbGbCtD
Tamoxifen—ABCG2—Methotrexate—multiple sclerosis	0.0119	0.0181	CbGbCtD
Tamoxifen—CYP3A7—Dexamethasone—multiple sclerosis	0.0109	0.0166	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0109	0.0166	CbGbCtD
Tamoxifen—CYP2C19—Prednisone—multiple sclerosis	0.0106	0.0161	CbGbCtD
Tamoxifen—CYP2E1—Dexamethasone—multiple sclerosis	0.0105	0.0161	CbGbCtD
Tamoxifen—CYP2B6—Dexamethasone—multiple sclerosis	0.0104	0.0158	CbGbCtD
Tamoxifen—ABCB1—Mitoxantrone—multiple sclerosis	0.0103	0.0157	CbGbCtD
Tamoxifen—ABCB1—Betamethasone—multiple sclerosis	0.00915	0.014	CbGbCtD
Tamoxifen—ABCB1—Prednisolone—multiple sclerosis	0.00903	0.0138	CbGbCtD
Tamoxifen—ABCB1—Prednisone—multiple sclerosis	0.00853	0.013	CbGbCtD
Tamoxifen—CYP3A4—Methylprednisolone—multiple sclerosis	0.00843	0.0129	CbGbCtD
Tamoxifen—CYP3A5—Dexamethasone—multiple sclerosis	0.00818	0.0125	CbGbCtD
Tamoxifen—CYP2C8—Dexamethasone—multiple sclerosis	0.00786	0.012	CbGbCtD
Tamoxifen—CYP2C19—Dexamethasone—multiple sclerosis	0.0066	0.0101	CbGbCtD
Tamoxifen—CYP3A4—Triamcinolone—multiple sclerosis	0.00639	0.00976	CbGbCtD
Tamoxifen—CYP3A4—Mitoxantrone—multiple sclerosis	0.00615	0.00939	CbGbCtD
Tamoxifen—CYP2C9—Dexamethasone—multiple sclerosis	0.00548	0.00837	CbGbCtD
Tamoxifen—CYP3A4—Betamethasone—multiple sclerosis	0.00548	0.00837	CbGbCtD
Tamoxifen—CYP3A4—Prednisolone—multiple sclerosis	0.00541	0.00826	CbGbCtD
Tamoxifen—ABCB1—Dexamethasone—multiple sclerosis	0.00532	0.00813	CbGbCtD
Tamoxifen—CYP3A4—Prednisone—multiple sclerosis	0.00511	0.0078	CbGbCtD
Tamoxifen—CYP2D6—Dexamethasone—multiple sclerosis	0.00501	0.00766	CbGbCtD
Tamoxifen—ABCB1—Methotrexate—multiple sclerosis	0.00428	0.00653	CbGbCtD
Tamoxifen—CYP3A4—Dexamethasone—multiple sclerosis	0.00319	0.00487	CbGbCtD
Tamoxifen—DHCR7—retina—multiple sclerosis	0.00134	0.0321	CbGeAlD
Tamoxifen—EBPL—nervous system—multiple sclerosis	0.00129	0.0309	CbGeAlD
Tamoxifen—EBPL—central nervous system—multiple sclerosis	0.00124	0.0297	CbGeAlD
Tamoxifen—SULT1A1—spinal cord—multiple sclerosis	0.00121	0.0291	CbGeAlD
Tamoxifen—EBPL—cerebellum—multiple sclerosis	0.00121	0.0291	CbGeAlD
Tamoxifen—SULT1A1—nervous system—multiple sclerosis	0.00102	0.0245	CbGeAlD
Tamoxifen—SULT1A1—central nervous system—multiple sclerosis	0.000985	0.0236	CbGeAlD
Tamoxifen—EBPL—brain—multiple sclerosis	0.000985	0.0236	CbGeAlD
Tamoxifen—DHCR7—medulla oblongata—multiple sclerosis	0.000969	0.0232	CbGeAlD
Tamoxifen—EBP—Azacitidine—Cladribine—multiple sclerosis	0.000967	1	CbGdCrCtD
Tamoxifen—SULT1A1—cerebellum—multiple sclerosis	0.000963	0.0231	CbGeAlD
Tamoxifen—ESRRA—medulla oblongata—multiple sclerosis	0.000954	0.0229	CbGeAlD
Tamoxifen—DHCR7—midbrain—multiple sclerosis	0.000885	0.0212	CbGeAlD
Tamoxifen—ESRRA—midbrain—multiple sclerosis	0.000872	0.0209	CbGeAlD
Tamoxifen—DHCR7—spinal cord—multiple sclerosis	0.000864	0.0207	CbGeAlD
Tamoxifen—ESRRA—spinal cord—multiple sclerosis	0.00085	0.0204	CbGeAlD
Tamoxifen—ESR2—brainstem—multiple sclerosis	0.000821	0.0197	CbGeAlD
Tamoxifen—SULT1A1—brain—multiple sclerosis	0.000782	0.0188	CbGeAlD
Tamoxifen—DHCR7—nervous system—multiple sclerosis	0.000728	0.0175	CbGeAlD
Tamoxifen—FMO1—nervous system—multiple sclerosis	0.000728	0.0175	CbGeAlD
Tamoxifen—ESRRA—nervous system—multiple sclerosis	0.000717	0.0172	CbGeAlD
Tamoxifen—DHCR7—central nervous system—multiple sclerosis	0.000701	0.0168	CbGeAlD
Tamoxifen—FMO1—central nervous system—multiple sclerosis	0.000701	0.0168	CbGeAlD
Tamoxifen—ESRRA—central nervous system—multiple sclerosis	0.00069	0.0165	CbGeAlD
Tamoxifen—DHCR7—cerebellum—multiple sclerosis	0.000685	0.0164	CbGeAlD
Tamoxifen—ESRRA—cerebellum—multiple sclerosis	0.000674	0.0162	CbGeAlD
Tamoxifen—FMO3—nervous system—multiple sclerosis	0.000629	0.0151	CbGeAlD
Tamoxifen—FMO3—central nervous system—multiple sclerosis	0.000606	0.0145	CbGeAlD
Tamoxifen—ESR1—brainstem—multiple sclerosis	0.000562	0.0135	CbGeAlD
Tamoxifen—DHCR7—brain—multiple sclerosis	0.000556	0.0133	CbGeAlD
Tamoxifen—FMO1—brain—multiple sclerosis	0.000556	0.0133	CbGeAlD
Tamoxifen—ESRRA—brain—multiple sclerosis	0.000548	0.0131	CbGeAlD
Tamoxifen—Loperamide—POMC—multiple sclerosis	0.000536	1	CrCbGaD
Tamoxifen—CES1—nervous system—multiple sclerosis	0.000497	0.0119	CbGeAlD
Tamoxifen—FMO3—brain—multiple sclerosis	0.000481	0.0115	CbGeAlD
Tamoxifen—CES1—central nervous system—multiple sclerosis	0.000478	0.0115	CbGeAlD
Tamoxifen—SIGMAR1—medulla oblongata—multiple sclerosis	0.000443	0.0106	CbGeAlD
Tamoxifen—ESR2—nervous system—multiple sclerosis	0.00043	0.0103	CbGeAlD
Tamoxifen—ESR2—central nervous system—multiple sclerosis	0.000414	0.00993	CbGeAlD
Tamoxifen—CYP2A6—cerebellum—multiple sclerosis	0.000407	0.00975	CbGeAlD
Tamoxifen—SIGMAR1—midbrain—multiple sclerosis	0.000405	0.00972	CbGeAlD
Tamoxifen—ESR2—cerebellum—multiple sclerosis	0.000405	0.00971	CbGeAlD
Tamoxifen—SIGMAR1—spinal cord—multiple sclerosis	0.000395	0.00948	CbGeAlD
Tamoxifen—CES1—brain—multiple sclerosis	0.00038	0.0091	CbGeAlD
Tamoxifen—CYP19A1—nervous system—multiple sclerosis	0.000339	0.00813	CbGeAlD
Tamoxifen—CYP2A6—brain—multiple sclerosis	0.00033	0.00792	CbGeAlD
Tamoxifen—ESR2—brain—multiple sclerosis	0.000329	0.00788	CbGeAlD
Tamoxifen—CYP19A1—central nervous system—multiple sclerosis	0.000326	0.00783	CbGeAlD
Tamoxifen—CYP1B1—nervous system—multiple sclerosis	0.000317	0.0076	CbGeAlD
Tamoxifen—ABCG2—medulla oblongata—multiple sclerosis	0.000314	0.00753	CbGeAlD
Tamoxifen—SIGMAR1—cerebellum—multiple sclerosis	0.000314	0.00752	CbGeAlD
Tamoxifen—CYP2D6—brainstem—multiple sclerosis	0.000309	0.0074	CbGeAlD
Tamoxifen—CYP1B1—central nervous system—multiple sclerosis	0.000305	0.00732	CbGeAlD
Tamoxifen—CYP1B1—cerebellum—multiple sclerosis	0.000298	0.00715	CbGeAlD
Tamoxifen—ESR1—nervous system—multiple sclerosis	0.000295	0.00706	CbGeAlD
Tamoxifen—ABCG2—midbrain—multiple sclerosis	0.000287	0.00688	CbGeAlD
Tamoxifen—ESR1—central nervous system—multiple sclerosis	0.000284	0.0068	CbGeAlD
Tamoxifen—ABCG2—spinal cord—multiple sclerosis	0.00028	0.00671	CbGeAlD
Tamoxifen—ESR1—cerebellum—multiple sclerosis	0.000277	0.00665	CbGeAlD
Tamoxifen—CYP2E1—medulla oblongata—multiple sclerosis	0.000272	0.00652	CbGeAlD
Tamoxifen—CYP19A1—brain—multiple sclerosis	0.000259	0.00621	CbGeAlD
Tamoxifen—SIGMAR1—brain—multiple sclerosis	0.000255	0.00611	CbGeAlD
Tamoxifen—CYP2E1—spinal cord—multiple sclerosis	0.000242	0.00581	CbGeAlD
Tamoxifen—CYP1B1—brain—multiple sclerosis	0.000242	0.00581	CbGeAlD
Tamoxifen—ESR1—brain—multiple sclerosis	0.000225	0.0054	CbGeAlD
Tamoxifen—CYP1A1—nervous system—multiple sclerosis	0.000224	0.00537	CbGeAlD
Tamoxifen—ABCG2—cerebellum—multiple sclerosis	0.000222	0.00532	CbGeAlD
Tamoxifen—CYP2B6—nervous system—multiple sclerosis	0.000218	0.00522	CbGeAlD
Tamoxifen—CYP1A1—central nervous system—multiple sclerosis	0.000216	0.00517	CbGeAlD
Tamoxifen—ABCB1—retina—multiple sclerosis	0.000214	0.00514	CbGeAlD
Tamoxifen—CYP2B6—central nervous system—multiple sclerosis	0.00021	0.00503	CbGeAlD
Tamoxifen—CYP2E1—nervous system—multiple sclerosis	0.000204	0.0049	CbGeAlD
Tamoxifen—CYP2E1—central nervous system—multiple sclerosis	0.000197	0.00472	CbGeAlD
Tamoxifen—CYP2E1—cerebellum—multiple sclerosis	0.000192	0.00461	CbGeAlD
Tamoxifen—CYP2C8—brain—multiple sclerosis	0.000185	0.00445	CbGeAlD
Tamoxifen—ABCG2—brain—multiple sclerosis	0.00018	0.00432	CbGeAlD
Tamoxifen—CYP1A1—brain—multiple sclerosis	0.000171	0.00411	CbGeAlD
Tamoxifen—CYP2B6—brain—multiple sclerosis	0.000166	0.00399	CbGeAlD
Tamoxifen—CYP3A4—nervous system—multiple sclerosis	0.000164	0.00394	CbGeAlD
Tamoxifen—CYP2D6—nervous system—multiple sclerosis	0.000162	0.00388	CbGeAlD
Tamoxifen—CYP3A4—central nervous system—multiple sclerosis	0.000158	0.00379	CbGeAlD
Tamoxifen—CYP2E1—brain—multiple sclerosis	0.000156	0.00374	CbGeAlD
Tamoxifen—CYP2D6—central nervous system—multiple sclerosis	0.000156	0.00373	CbGeAlD
Tamoxifen—ABCB1—medulla oblongata—multiple sclerosis	0.000155	0.00371	CbGeAlD
Tamoxifen—CYP2D6—cerebellum—multiple sclerosis	0.000152	0.00365	CbGeAlD
Tamoxifen—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000146	0.000787	CcSEcCtD
Tamoxifen—Dysgeusia—Triamcinolone—multiple sclerosis	0.000145	0.000782	CcSEcCtD
Tamoxifen—Nausea—Cladribine—multiple sclerosis	0.000145	0.00078	CcSEcCtD
Tamoxifen—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000144	0.000775	CcSEcCtD
Tamoxifen—Back pain—Triamcinolone—multiple sclerosis	0.000143	0.000772	CcSEcCtD
Tamoxifen—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000143	0.00077	CcSEcCtD
Tamoxifen—ABCB1—midbrain—multiple sclerosis	0.000142	0.00339	CbGeAlD
Tamoxifen—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000141	0.00076	CcSEcCtD
Tamoxifen—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000139	0.000751	CcSEcCtD
Tamoxifen—Hypertension—Prednisolone—multiple sclerosis	0.000139	0.000749	CcSEcCtD
Tamoxifen—Fatigue—Mitoxantrone—multiple sclerosis	0.000138	0.000744	CcSEcCtD
Tamoxifen—ABCB1—spinal cord—multiple sclerosis	0.000138	0.00331	CbGeAlD
Tamoxifen—Arrhythmia—Betamethasone—multiple sclerosis	0.000138	0.000743	CcSEcCtD
Tamoxifen—Arrhythmia—Dexamethasone—multiple sclerosis	0.000138	0.000743	CcSEcCtD
Tamoxifen—Pancreatitis—Methotrexate—multiple sclerosis	0.000138	0.000742	CcSEcCtD
Tamoxifen—Constipation—Mitoxantrone—multiple sclerosis	0.000137	0.000738	CcSEcCtD
Tamoxifen—Pain—Mitoxantrone—multiple sclerosis	0.000137	0.000738	CcSEcCtD
Tamoxifen—Alopecia—Dexamethasone—multiple sclerosis	0.000136	0.000735	CcSEcCtD
Tamoxifen—Alopecia—Betamethasone—multiple sclerosis	0.000136	0.000735	CcSEcCtD
Tamoxifen—Diarrhoea—Azathioprine—multiple sclerosis	0.000136	0.000731	CcSEcCtD
Tamoxifen—Discomfort—Prednisolone—multiple sclerosis	0.000135	0.00073	CcSEcCtD
Tamoxifen—Angioedema—Triamcinolone—multiple sclerosis	0.000135	0.000729	CcSEcCtD
Tamoxifen—Haemoglobin—Prednisone—multiple sclerosis	0.000135	0.000728	CcSEcCtD
Tamoxifen—Angioedema—Methylprednisolone—multiple sclerosis	0.000135	0.000728	CcSEcCtD
Tamoxifen—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000135	0.000725	CcSEcCtD
Tamoxifen—Haemorrhage—Prednisone—multiple sclerosis	0.000134	0.000725	CcSEcCtD
Tamoxifen—Erythema—Dexamethasone—multiple sclerosis	0.000134	0.000724	CcSEcCtD
Tamoxifen—Erythema—Betamethasone—multiple sclerosis	0.000134	0.000724	CcSEcCtD
Tamoxifen—Pancytopenia—Methotrexate—multiple sclerosis	0.000133	0.000718	CcSEcCtD
Tamoxifen—Oedema—Prednisolone—multiple sclerosis	0.000131	0.000708	CcSEcCtD
Tamoxifen—Neutropenia—Methotrexate—multiple sclerosis	0.000131	0.000707	CcSEcCtD
Tamoxifen—Dizziness—Azathioprine—multiple sclerosis	0.000131	0.000706	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000131	0.000706	CcSEcCtD
Tamoxifen—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000129	0.000697	CcSEcCtD
Tamoxifen—Cough—Triamcinolone—multiple sclerosis	0.000129	0.000697	CcSEcCtD
Tamoxifen—Hypertension—Triamcinolone—multiple sclerosis	0.000128	0.000689	CcSEcCtD
Tamoxifen—Hypertension—Methylprednisolone—multiple sclerosis	0.000128	0.000688	CcSEcCtD
Tamoxifen—Urticaria—Mitoxantrone—multiple sclerosis	0.000127	0.000686	CcSEcCtD
Tamoxifen—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000127	0.000685	CcSEcCtD
Tamoxifen—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000127	0.000683	CcSEcCtD
Tamoxifen—Myalgia—Triamcinolone—multiple sclerosis	0.000126	0.00068	CcSEcCtD
Tamoxifen—Vomiting—Azathioprine—multiple sclerosis	0.000126	0.000679	CcSEcCtD
Tamoxifen—Pneumonia—Methotrexate—multiple sclerosis	0.000126	0.000678	CcSEcCtD
Tamoxifen—Myalgia—Methylprednisolone—multiple sclerosis	0.000126	0.000678	CcSEcCtD
Tamoxifen—Arthralgia—Methylprednisolone—multiple sclerosis	0.000126	0.000678	CcSEcCtD
Tamoxifen—Anxiety—Methylprednisolone—multiple sclerosis	0.000125	0.000676	CcSEcCtD
Tamoxifen—Rash—Azathioprine—multiple sclerosis	0.000125	0.000673	CcSEcCtD
Tamoxifen—Dermatitis—Azathioprine—multiple sclerosis	0.000125	0.000673	CcSEcCtD
Tamoxifen—Depression—Methotrexate—multiple sclerosis	0.000125	0.000673	CcSEcCtD
Tamoxifen—Flushing—Prednisone—multiple sclerosis	0.000125	0.000672	CcSEcCtD
Tamoxifen—Discomfort—Triamcinolone—multiple sclerosis	0.000125	0.000671	CcSEcCtD
Tamoxifen—Discomfort—Methylprednisolone—multiple sclerosis	0.000124	0.00067	CcSEcCtD
Tamoxifen—Headache—Azathioprine—multiple sclerosis	0.000124	0.000669	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000124	0.000669	CcSEcCtD
Tamoxifen—CYP2D6—brain—multiple sclerosis	0.000124	0.00296	CbGeAlD
Tamoxifen—Dry mouth—Triamcinolone—multiple sclerosis	0.000123	0.000665	CcSEcCtD
Tamoxifen—Angioedema—Dexamethasone—multiple sclerosis	0.000123	0.000662	CcSEcCtD
Tamoxifen—Angioedema—Betamethasone—multiple sclerosis	0.000123	0.000662	CcSEcCtD
Tamoxifen—Oedema—Triamcinolone—multiple sclerosis	0.000121	0.000651	CcSEcCtD
Tamoxifen—Arrhythmia—Prednisone—multiple sclerosis	0.00012	0.000647	CcSEcCtD
Tamoxifen—Infection—Triamcinolone—multiple sclerosis	0.00012	0.000647	CcSEcCtD
Tamoxifen—Sweating—Methotrexate—multiple sclerosis	0.00012	0.000647	CcSEcCtD
Tamoxifen—Infection—Methylprednisolone—multiple sclerosis	0.00012	0.000646	CcSEcCtD
Tamoxifen—Insomnia—Prednisolone—multiple sclerosis	0.000119	0.000641	CcSEcCtD
Tamoxifen—Alopecia—Prednisone—multiple sclerosis	0.000119	0.00064	CcSEcCtD
Tamoxifen—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000118	0.000636	CcSEcCtD
Tamoxifen—Paraesthesia—Prednisolone—multiple sclerosis	0.000118	0.000636	CcSEcCtD
Tamoxifen—Nausea—Azathioprine—multiple sclerosis	0.000118	0.000634	CcSEcCtD
Tamoxifen—Erythema—Prednisone—multiple sclerosis	0.000117	0.000631	CcSEcCtD
Tamoxifen—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000117	0.00063	CcSEcCtD
Tamoxifen—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000117	0.000628	CcSEcCtD
Tamoxifen—ABCB1—nervous system—multiple sclerosis	0.000116	0.00279	CbGeAlD
Tamoxifen—Hypertension—Dexamethasone—multiple sclerosis	0.000116	0.000625	CcSEcCtD
Tamoxifen—Hypertension—Betamethasone—multiple sclerosis	0.000116	0.000625	CcSEcCtD
Tamoxifen—Asthenia—Mitoxantrone—multiple sclerosis	0.000115	0.00062	CcSEcCtD
Tamoxifen—Myalgia—Dexamethasone—multiple sclerosis	0.000114	0.000617	CcSEcCtD
Tamoxifen—Myalgia—Betamethasone—multiple sclerosis	0.000114	0.000617	CcSEcCtD
Tamoxifen—Anxiety—Dexamethasone—multiple sclerosis	0.000114	0.000614	CcSEcCtD
Tamoxifen—Anxiety—Betamethasone—multiple sclerosis	0.000114	0.000614	CcSEcCtD
Tamoxifen—Discomfort—Dexamethasone—multiple sclerosis	0.000113	0.000609	CcSEcCtD
Tamoxifen—Discomfort—Betamethasone—multiple sclerosis	0.000113	0.000609	CcSEcCtD
Tamoxifen—Haemoglobin—Methotrexate—multiple sclerosis	0.000113	0.000609	CcSEcCtD
Tamoxifen—Pain—Prednisolone—multiple sclerosis	0.000112	0.000606	CcSEcCtD
Tamoxifen—Haemorrhage—Methotrexate—multiple sclerosis	0.000112	0.000606	CcSEcCtD
Tamoxifen—Hepatitis—Methotrexate—multiple sclerosis	0.000112	0.000606	CcSEcCtD
Tamoxifen—ABCB1—central nervous system—multiple sclerosis	0.000112	0.00269	CbGeAlD
Tamoxifen—Pharyngitis—Methotrexate—multiple sclerosis	0.000111	0.000601	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00011	0.000594	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00011	0.000592	CcSEcCtD
Tamoxifen—Oedema—Betamethasone—multiple sclerosis	0.00011	0.000591	CcSEcCtD
Tamoxifen—Oedema—Dexamethasone—multiple sclerosis	0.00011	0.000591	CcSEcCtD
Tamoxifen—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00011	0.000591	CcSEcCtD
Tamoxifen—ABCB1—cerebellum—multiple sclerosis	0.000109	0.00263	CbGeAlD
Tamoxifen—Insomnia—Triamcinolone—multiple sclerosis	0.000109	0.000589	CcSEcCtD
Tamoxifen—Insomnia—Methylprednisolone—multiple sclerosis	0.000109	0.000588	CcSEcCtD
Tamoxifen—Infection—Dexamethasone—multiple sclerosis	0.000109	0.000587	CcSEcCtD
Tamoxifen—Infection—Betamethasone—multiple sclerosis	0.000109	0.000587	CcSEcCtD
Tamoxifen—Paraesthesia—Triamcinolone—multiple sclerosis	0.000109	0.000585	CcSEcCtD
Tamoxifen—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000108	0.000584	CcSEcCtD
Tamoxifen—Visual impairment—Methotrexate—multiple sclerosis	0.000108	0.000584	CcSEcCtD
Tamoxifen—Anaemia—Prednisone—multiple sclerosis	0.000108	0.000583	CcSEcCtD
Tamoxifen—Dyspnoea—Triamcinolone—multiple sclerosis	0.000108	0.000581	CcSEcCtD
Tamoxifen—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000107	0.000579	CcSEcCtD
Tamoxifen—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000107	0.000579	CcSEcCtD
Tamoxifen—Angioedema—Prednisone—multiple sclerosis	0.000107	0.000576	CcSEcCtD
Tamoxifen—Dyspepsia—Triamcinolone—multiple sclerosis	0.000106	0.000573	CcSEcCtD
Tamoxifen—Erythema multiforme—Methotrexate—multiple sclerosis	0.000106	0.000573	CcSEcCtD
Tamoxifen—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000106	0.000572	CcSEcCtD
Tamoxifen—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000106	0.000571	CcSEcCtD
Tamoxifen—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000106	0.000571	CcSEcCtD
Tamoxifen—Anorexia—Betamethasone—multiple sclerosis	0.000105	0.000563	CcSEcCtD
Tamoxifen—Anorexia—Dexamethasone—multiple sclerosis	0.000105	0.000563	CcSEcCtD
Tamoxifen—Urticaria—Prednisolone—multiple sclerosis	0.000104	0.000563	CcSEcCtD
Tamoxifen—Fatigue—Triamcinolone—multiple sclerosis	0.000104	0.000562	CcSEcCtD
Tamoxifen—Fatigue—Methylprednisolone—multiple sclerosis	0.000104	0.00056	CcSEcCtD
Tamoxifen—Pain—Triamcinolone—multiple sclerosis	0.000103	0.000557	CcSEcCtD
Tamoxifen—Vomiting—Mitoxantrone—multiple sclerosis	0.000102	0.000549	CcSEcCtD
Tamoxifen—Hypertension—Prednisone—multiple sclerosis	0.000101	0.000545	CcSEcCtD
Tamoxifen—Rash—Mitoxantrone—multiple sclerosis	0.000101	0.000544	CcSEcCtD
Tamoxifen—Dermatitis—Mitoxantrone—multiple sclerosis	0.000101	0.000544	CcSEcCtD
Tamoxifen—Headache—Mitoxantrone—multiple sclerosis	0.0001	0.000541	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	9.99e-05	0.000539	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	9.99e-05	0.000539	CcSEcCtD
Tamoxifen—Arthralgia—Prednisone—multiple sclerosis	9.96e-05	0.000537	CcSEcCtD
Tamoxifen—Myalgia—Prednisone—multiple sclerosis	9.96e-05	0.000537	CcSEcCtD
Tamoxifen—Anxiety—Prednisone—multiple sclerosis	9.93e-05	0.000535	CcSEcCtD
Tamoxifen—Alopecia—Methotrexate—multiple sclerosis	9.93e-05	0.000535	CcSEcCtD
Tamoxifen—Insomnia—Betamethasone—multiple sclerosis	9.92e-05	0.000535	CcSEcCtD
Tamoxifen—Insomnia—Dexamethasone—multiple sclerosis	9.92e-05	0.000535	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	9.86e-05	0.000532	CcSEcCtD
Tamoxifen—Paraesthesia—Dexamethasone—multiple sclerosis	9.85e-05	0.000531	CcSEcCtD
Tamoxifen—Paraesthesia—Betamethasone—multiple sclerosis	9.85e-05	0.000531	CcSEcCtD
Tamoxifen—Discomfort—Prednisone—multiple sclerosis	9.84e-05	0.000531	CcSEcCtD
Tamoxifen—Erythema—Methotrexate—multiple sclerosis	9.78e-05	0.000527	CcSEcCtD
Tamoxifen—Hypersensitivity—Prednisolone—multiple sclerosis	9.68e-05	0.000522	CcSEcCtD
Tamoxifen—Dyspepsia—Betamethasone—multiple sclerosis	9.65e-05	0.00052	CcSEcCtD
Tamoxifen—Dyspepsia—Dexamethasone—multiple sclerosis	9.65e-05	0.00052	CcSEcCtD
Tamoxifen—Urticaria—Triamcinolone—multiple sclerosis	9.6e-05	0.000518	CcSEcCtD
Tamoxifen—Urticaria—Methylprednisolone—multiple sclerosis	9.58e-05	0.000516	CcSEcCtD
Tamoxifen—Dysgeusia—Methotrexate—multiple sclerosis	9.58e-05	0.000516	CcSEcCtD
Tamoxifen—Oedema—Prednisone—multiple sclerosis	9.55e-05	0.000515	CcSEcCtD
Tamoxifen—Abdominal pain—Methylprednisolone—multiple sclerosis	9.53e-05	0.000514	CcSEcCtD
Tamoxifen—Decreased appetite—Betamethasone—multiple sclerosis	9.53e-05	0.000514	CcSEcCtD
Tamoxifen—Decreased appetite—Dexamethasone—multiple sclerosis	9.53e-05	0.000514	CcSEcCtD
Tamoxifen—Nausea—Mitoxantrone—multiple sclerosis	9.51e-05	0.000513	CcSEcCtD
Tamoxifen—Infection—Prednisone—multiple sclerosis	9.49e-05	0.000511	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Betamethasone—multiple sclerosis	9.47e-05	0.00051	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	9.47e-05	0.00051	CcSEcCtD
Tamoxifen—Back pain—Methotrexate—multiple sclerosis	9.46e-05	0.00051	CcSEcCtD
Tamoxifen—Fatigue—Dexamethasone—multiple sclerosis	9.45e-05	0.00051	CcSEcCtD
Tamoxifen—Fatigue—Betamethasone—multiple sclerosis	9.45e-05	0.00051	CcSEcCtD
Tamoxifen—Pain—Dexamethasone—multiple sclerosis	9.38e-05	0.000505	CcSEcCtD
Tamoxifen—Pain—Betamethasone—multiple sclerosis	9.38e-05	0.000505	CcSEcCtD
Tamoxifen—Hyperhidrosis—Prednisone—multiple sclerosis	9.23e-05	0.000498	CcSEcCtD
Tamoxifen—Anorexia—Prednisone—multiple sclerosis	9.1e-05	0.000491	CcSEcCtD
Tamoxifen—Anaemia—Methotrexate—multiple sclerosis	9.04e-05	0.000487	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Betamethasone—multiple sclerosis	8.97e-05	0.000483	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Dexamethasone—multiple sclerosis	8.97e-05	0.000483	CcSEcCtD
Tamoxifen—Hypersensitivity—Triamcinolone—multiple sclerosis	8.9e-05	0.00048	CcSEcCtD
Tamoxifen—ABCB1—brain—multiple sclerosis	8.89e-05	0.00213	CbGeAlD
Tamoxifen—Hypersensitivity—Methylprednisolone—multiple sclerosis	8.88e-05	0.000479	CcSEcCtD
Tamoxifen—Leukopenia—Methotrexate—multiple sclerosis	8.75e-05	0.000472	CcSEcCtD
Tamoxifen—Urticaria—Dexamethasone—multiple sclerosis	8.71e-05	0.00047	CcSEcCtD
Tamoxifen—Urticaria—Betamethasone—multiple sclerosis	8.71e-05	0.00047	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Prednisone—multiple sclerosis	8.7e-05	0.000469	CcSEcCtD
Tamoxifen—Dizziness—Prednisolone—multiple sclerosis	8.69e-05	0.000468	CcSEcCtD
Tamoxifen—Asthenia—Triamcinolone—multiple sclerosis	8.67e-05	0.000467	CcSEcCtD
Tamoxifen—Abdominal pain—Dexamethasone—multiple sclerosis	8.67e-05	0.000467	CcSEcCtD
Tamoxifen—Abdominal pain—Betamethasone—multiple sclerosis	8.67e-05	0.000467	CcSEcCtD
Tamoxifen—Asthenia—Methylprednisolone—multiple sclerosis	8.65e-05	0.000466	CcSEcCtD
Tamoxifen—Insomnia—Prednisone—multiple sclerosis	8.64e-05	0.000466	CcSEcCtD
Tamoxifen—Paraesthesia—Prednisone—multiple sclerosis	8.57e-05	0.000462	CcSEcCtD
Tamoxifen—Pruritus—Triamcinolone—multiple sclerosis	8.55e-05	0.000461	CcSEcCtD
Tamoxifen—Cough—Methotrexate—multiple sclerosis	8.53e-05	0.00046	CcSEcCtD
Tamoxifen—Pruritus—Methylprednisolone—multiple sclerosis	8.53e-05	0.00046	CcSEcCtD
Tamoxifen—Dyspepsia—Prednisone—multiple sclerosis	8.41e-05	0.000453	CcSEcCtD
Tamoxifen—Myalgia—Methotrexate—multiple sclerosis	8.33e-05	0.000449	CcSEcCtD
Tamoxifen—Arthralgia—Methotrexate—multiple sclerosis	8.33e-05	0.000449	CcSEcCtD
Tamoxifen—Chest pain—Methotrexate—multiple sclerosis	8.33e-05	0.000449	CcSEcCtD
Tamoxifen—Decreased appetite—Prednisone—multiple sclerosis	8.3e-05	0.000447	CcSEcCtD
Tamoxifen—Rash—Prednisolone—multiple sclerosis	8.29e-05	0.000447	CcSEcCtD
Tamoxifen—Dermatitis—Prednisolone—multiple sclerosis	8.28e-05	0.000446	CcSEcCtD
Tamoxifen—Diarrhoea—Methylprednisolone—multiple sclerosis	8.25e-05	0.000445	CcSEcCtD
Tamoxifen—Fatigue—Prednisone—multiple sclerosis	8.23e-05	0.000444	CcSEcCtD
Tamoxifen—Headache—Prednisolone—multiple sclerosis	8.23e-05	0.000444	CcSEcCtD
Tamoxifen—Discomfort—Methotrexate—multiple sclerosis	8.23e-05	0.000443	CcSEcCtD
Tamoxifen—Constipation—Prednisone—multiple sclerosis	8.17e-05	0.00044	CcSEcCtD
Tamoxifen—Dizziness—Triamcinolone—multiple sclerosis	7.99e-05	0.000431	CcSEcCtD
Tamoxifen—Dizziness—Methylprednisolone—multiple sclerosis	7.97e-05	0.00043	CcSEcCtD
Tamoxifen—Infection—Methotrexate—multiple sclerosis	7.93e-05	0.000427	CcSEcCtD
Tamoxifen—Asthenia—Betamethasone—multiple sclerosis	7.87e-05	0.000424	CcSEcCtD
Tamoxifen—Asthenia—Dexamethasone—multiple sclerosis	7.87e-05	0.000424	CcSEcCtD
Tamoxifen—Thrombocytopenia—Methotrexate—multiple sclerosis	7.81e-05	0.000421	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Prednisone—multiple sclerosis	7.81e-05	0.000421	CcSEcCtD
Tamoxifen—Nausea—Prednisolone—multiple sclerosis	7.81e-05	0.000421	CcSEcCtD
Tamoxifen—Pruritus—Dexamethasone—multiple sclerosis	7.76e-05	0.000418	CcSEcCtD
Tamoxifen—Pruritus—Betamethasone—multiple sclerosis	7.76e-05	0.000418	CcSEcCtD
Tamoxifen—Hyperhidrosis—Methotrexate—multiple sclerosis	7.72e-05	0.000416	CcSEcCtD
Tamoxifen—Vomiting—Triamcinolone—multiple sclerosis	7.68e-05	0.000414	CcSEcCtD
Tamoxifen—Vomiting—Methylprednisolone—multiple sclerosis	7.67e-05	0.000413	CcSEcCtD
Tamoxifen—Rash—Triamcinolone—multiple sclerosis	7.62e-05	0.000411	CcSEcCtD
Tamoxifen—Dermatitis—Triamcinolone—multiple sclerosis	7.61e-05	0.00041	CcSEcCtD
Tamoxifen—Anorexia—Methotrexate—multiple sclerosis	7.61e-05	0.00041	CcSEcCtD
Tamoxifen—Rash—Methylprednisolone—multiple sclerosis	7.6e-05	0.00041	CcSEcCtD
Tamoxifen—Dermatitis—Methylprednisolone—multiple sclerosis	7.6e-05	0.000409	CcSEcCtD
Tamoxifen—Urticaria—Prednisone—multiple sclerosis	7.59e-05	0.000409	CcSEcCtD
Tamoxifen—Headache—Triamcinolone—multiple sclerosis	7.57e-05	0.000408	CcSEcCtD
Tamoxifen—Headache—Methylprednisolone—multiple sclerosis	7.55e-05	0.000407	CcSEcCtD
Tamoxifen—Abdominal pain—Prednisone—multiple sclerosis	7.55e-05	0.000407	CcSEcCtD
Tamoxifen—Diarrhoea—Dexamethasone—multiple sclerosis	7.5e-05	0.000404	CcSEcCtD
Tamoxifen—Diarrhoea—Betamethasone—multiple sclerosis	7.5e-05	0.000404	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	7.27e-05	0.000392	CcSEcCtD
Tamoxifen—Dizziness—Dexamethasone—multiple sclerosis	7.25e-05	0.000391	CcSEcCtD
Tamoxifen—Dizziness—Betamethasone—multiple sclerosis	7.25e-05	0.000391	CcSEcCtD
Tamoxifen—Insomnia—Methotrexate—multiple sclerosis	7.22e-05	0.000389	CcSEcCtD
Tamoxifen—Nausea—Triamcinolone—multiple sclerosis	7.18e-05	0.000387	CcSEcCtD
Tamoxifen—Paraesthesia—Methotrexate—multiple sclerosis	7.17e-05	0.000386	CcSEcCtD
Tamoxifen—Nausea—Methylprednisolone—multiple sclerosis	7.16e-05	0.000386	CcSEcCtD
Tamoxifen—Dyspnoea—Methotrexate—multiple sclerosis	7.12e-05	0.000384	CcSEcCtD
Tamoxifen—Hypersensitivity—Prednisone—multiple sclerosis	7.04e-05	0.000379	CcSEcCtD
Tamoxifen—Dyspepsia—Methotrexate—multiple sclerosis	7.03e-05	0.000379	CcSEcCtD
Tamoxifen—Vomiting—Dexamethasone—multiple sclerosis	6.97e-05	0.000376	CcSEcCtD
Tamoxifen—Vomiting—Betamethasone—multiple sclerosis	6.97e-05	0.000376	CcSEcCtD
Tamoxifen—Decreased appetite—Methotrexate—multiple sclerosis	6.94e-05	0.000374	CcSEcCtD
Tamoxifen—Rash—Dexamethasone—multiple sclerosis	6.91e-05	0.000373	CcSEcCtD
Tamoxifen—Rash—Betamethasone—multiple sclerosis	6.91e-05	0.000373	CcSEcCtD
Tamoxifen—Dermatitis—Dexamethasone—multiple sclerosis	6.91e-05	0.000372	CcSEcCtD
Tamoxifen—Dermatitis—Betamethasone—multiple sclerosis	6.91e-05	0.000372	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Methotrexate—multiple sclerosis	6.89e-05	0.000371	CcSEcCtD
Tamoxifen—Fatigue—Methotrexate—multiple sclerosis	6.88e-05	0.000371	CcSEcCtD
Tamoxifen—Headache—Dexamethasone—multiple sclerosis	6.87e-05	0.00037	CcSEcCtD
Tamoxifen—Headache—Betamethasone—multiple sclerosis	6.87e-05	0.00037	CcSEcCtD
Tamoxifen—Asthenia—Prednisone—multiple sclerosis	6.85e-05	0.000369	CcSEcCtD
Tamoxifen—Pain—Methotrexate—multiple sclerosis	6.82e-05	0.000368	CcSEcCtD
Tamoxifen—Pruritus—Prednisone—multiple sclerosis	6.76e-05	0.000364	CcSEcCtD
Tamoxifen—Diarrhoea—Prednisone—multiple sclerosis	6.53e-05	0.000352	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Methotrexate—multiple sclerosis	6.53e-05	0.000352	CcSEcCtD
Tamoxifen—Nausea—Dexamethasone—multiple sclerosis	6.51e-05	0.000351	CcSEcCtD
Tamoxifen—Nausea—Betamethasone—multiple sclerosis	6.51e-05	0.000351	CcSEcCtD
Tamoxifen—Urticaria—Methotrexate—multiple sclerosis	6.34e-05	0.000342	CcSEcCtD
Tamoxifen—Dizziness—Prednisone—multiple sclerosis	6.31e-05	0.00034	CcSEcCtD
Tamoxifen—Abdominal pain—Methotrexate—multiple sclerosis	6.31e-05	0.00034	CcSEcCtD
Tamoxifen—Vomiting—Prednisone—multiple sclerosis	6.07e-05	0.000327	CcSEcCtD
Tamoxifen—Rash—Prednisone—multiple sclerosis	6.02e-05	0.000325	CcSEcCtD
Tamoxifen—Dermatitis—Prednisone—multiple sclerosis	6.02e-05	0.000324	CcSEcCtD
Tamoxifen—Headache—Prednisone—multiple sclerosis	5.98e-05	0.000322	CcSEcCtD
Tamoxifen—Hypersensitivity—Methotrexate—multiple sclerosis	5.88e-05	0.000317	CcSEcCtD
Tamoxifen—Asthenia—Methotrexate—multiple sclerosis	5.73e-05	0.000309	CcSEcCtD
Tamoxifen—Nausea—Prednisone—multiple sclerosis	5.67e-05	0.000306	CcSEcCtD
Tamoxifen—Pruritus—Methotrexate—multiple sclerosis	5.65e-05	0.000304	CcSEcCtD
Tamoxifen—Diarrhoea—Methotrexate—multiple sclerosis	5.46e-05	0.000294	CcSEcCtD
Tamoxifen—Dizziness—Methotrexate—multiple sclerosis	5.28e-05	0.000284	CcSEcCtD
Tamoxifen—Vomiting—Methotrexate—multiple sclerosis	5.07e-05	0.000274	CcSEcCtD
Tamoxifen—Rash—Methotrexate—multiple sclerosis	5.03e-05	0.000271	CcSEcCtD
Tamoxifen—Dermatitis—Methotrexate—multiple sclerosis	5.03e-05	0.000271	CcSEcCtD
Tamoxifen—Headache—Methotrexate—multiple sclerosis	5e-05	0.00027	CcSEcCtD
Tamoxifen—Nausea—Methotrexate—multiple sclerosis	4.74e-05	0.000256	CcSEcCtD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	2.57e-05	0.000221	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TAGAP—multiple sclerosis	2.56e-05	0.00022	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GPC5—multiple sclerosis	2.54e-05	0.000219	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	2.53e-05	0.000217	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	2.53e-05	0.000217	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GPC5—multiple sclerosis	2.52e-05	0.000217	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—APOE—multiple sclerosis	2.5e-05	0.000215	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—POMC—multiple sclerosis	2.49e-05	0.000214	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—BCHE—multiple sclerosis	2.48e-05	0.000214	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—VDR—multiple sclerosis	2.48e-05	0.000214	CbGpPWpGaD
Tamoxifen—CYP1A1—Biological oxidations—POMC—multiple sclerosis	2.48e-05	0.000213	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.47e-05	0.000213	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—SRM—multiple sclerosis	2.45e-05	0.000211	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	2.44e-05	0.00021	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	2.44e-05	0.00021	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—PABPC1—multiple sclerosis	2.41e-05	0.000207	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—RRM1—multiple sclerosis	2.41e-05	0.000207	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	2.4e-05	0.000206	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—ALB—multiple sclerosis	2.4e-05	0.000206	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—VDR—multiple sclerosis	2.37e-05	0.000204	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—ALB—multiple sclerosis	2.35e-05	0.000202	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	2.35e-05	0.000202	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—MAPK1—multiple sclerosis	2.33e-05	0.000201	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—APOE—multiple sclerosis	2.32e-05	0.000199	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—RRM1—multiple sclerosis	2.32e-05	0.000199	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GPC5—multiple sclerosis	2.31e-05	0.000199	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.31e-05	0.000198	CbGpPWpGaD
Tamoxifen—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.29e-05	0.000197	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—ALB—multiple sclerosis	2.27e-05	0.000195	CbGpPWpGaD
Tamoxifen—CYP2C8—Biological oxidations—POMC—multiple sclerosis	2.27e-05	0.000195	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—S1PR1—multiple sclerosis	2.23e-05	0.000192	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—SRM—multiple sclerosis	2.19e-05	0.000188	CbGpPWpGaD
Tamoxifen—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	2.19e-05	0.000188	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—RPL5—multiple sclerosis	2.17e-05	0.000187	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—GPC5—multiple sclerosis	2.17e-05	0.000187	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—POMC—multiple sclerosis	2.14e-05	0.000184	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—SRM—multiple sclerosis	2.13e-05	0.000184	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.13e-05	0.000183	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.13e-05	0.000183	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—RRM1—multiple sclerosis	2.11e-05	0.000181	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—RRM1—multiple sclerosis	2.09e-05	0.00018	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.07e-05	0.000178	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	2.04e-05	0.000175	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	2.04e-05	0.000175	CbGpPWpGaD
Tamoxifen—CYP2C19—Biological oxidations—POMC—multiple sclerosis	2.03e-05	0.000174	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—SRM—multiple sclerosis	2.01e-05	0.000173	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	2e-05	0.000172	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	2e-05	0.000172	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—SRM—multiple sclerosis	1.99e-05	0.000171	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	1.99e-05	0.000171	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	1.99e-05	0.000171	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—POMC—multiple sclerosis	1.99e-05	0.000171	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.99e-05	0.000171	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—TNF—multiple sclerosis	1.99e-05	0.000171	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.98e-05	0.00017	CbGpPWpGaD
Tamoxifen—ESR2—Generic Transcription Pathway—MYC—multiple sclerosis	1.96e-05	0.000168	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—ALB—multiple sclerosis	1.95e-05	0.000168	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.94e-05	0.000167	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.94e-05	0.000167	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—RRM1—multiple sclerosis	1.92e-05	0.000165	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RGS1—multiple sclerosis	1.9e-05	0.000163	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	1.88e-05	0.000162	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	1.88e-05	0.000162	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.87e-05	0.000161	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GPC5—multiple sclerosis	1.86e-05	0.00016	CbGpPWpGaD
Tamoxifen—CYP2D6—Biological oxidations—POMC—multiple sclerosis	1.86e-05	0.00016	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.85e-05	0.000159	CbGpPWpGaD
Tamoxifen—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.85e-05	0.000159	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.84e-05	0.000158	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—BCHE—multiple sclerosis	1.83e-05	0.000157	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.83e-05	0.000157	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GPC5—multiple sclerosis	1.83e-05	0.000157	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GPC5—multiple sclerosis	1.82e-05	0.000157	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—ALB—multiple sclerosis	1.82e-05	0.000156	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—GPR65—multiple sclerosis	1.8e-05	0.000155	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.8e-05	0.000155	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—IL6—multiple sclerosis	1.79e-05	0.000154	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—APOE—multiple sclerosis	1.78e-05	0.000153	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	1.73e-05	0.000148	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	1.73e-05	0.000148	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GPC5—multiple sclerosis	1.72e-05	0.000148	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—PGR—multiple sclerosis	1.71e-05	0.000147	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—SRM—multiple sclerosis	1.7e-05	0.000147	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.69e-05	0.000145	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CXCL13—multiple sclerosis	1.65e-05	0.000142	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCR1—multiple sclerosis	1.65e-05	0.000142	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.6e-05	0.000138	CbGpPWpGaD
Tamoxifen—CYP1A2—Biological oxidations—POMC—multiple sclerosis	1.58e-05	0.000136	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.58e-05	0.000136	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—RRM1—multiple sclerosis	1.55e-05	0.000133	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.54e-05	0.000133	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.54e-05	0.000132	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.54e-05	0.000132	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—POMC—multiple sclerosis	1.53e-05	0.000132	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—RRM1—multiple sclerosis	1.51e-05	0.00013	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—RRM1—multiple sclerosis	1.51e-05	0.00013	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.51e-05	0.000129	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.5e-05	0.000129	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.5e-05	0.000129	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—APOE—multiple sclerosis	1.49e-05	0.000129	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—MYC—multiple sclerosis	1.48e-05	0.000127	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.46e-05	0.000126	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—RRM1—multiple sclerosis	1.43e-05	0.000123	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.42e-05	0.000122	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.42e-05	0.000122	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.41e-05	0.000121	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.41e-05	0.000121	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.4e-05	0.000121	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.4e-05	0.000121	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.4e-05	0.00012	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—ALB—multiple sclerosis	1.4e-05	0.00012	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—BCHE—multiple sclerosis	1.38e-05	0.000119	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GPC5—multiple sclerosis	1.38e-05	0.000118	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.37e-05	0.000118	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—BCHE—multiple sclerosis	1.33e-05	0.000114	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SRM—multiple sclerosis	1.32e-05	0.000113	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.31e-05	0.000112	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.3e-05	0.000111	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.29e-05	0.00011	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—POMC—multiple sclerosis	1.28e-05	0.00011	CbGpPWpGaD
Tamoxifen—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.22e-05	0.000105	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.22e-05	0.000105	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—BCHE—multiple sclerosis	1.21e-05	0.000104	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.2e-05	0.000103	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.2e-05	0.000103	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.2e-05	0.000103	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—VDR—multiple sclerosis	1.2e-05	0.000103	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCL3—multiple sclerosis	1.17e-05	0.000101	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.17e-05	0.000101	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—ALB—multiple sclerosis	1.17e-05	0.000101	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.17e-05	0.0001	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—RRM1—multiple sclerosis	1.14e-05	9.8e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTGER4—multiple sclerosis	1.13e-05	9.72e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PGR—multiple sclerosis	1.11e-05	9.57e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.11e-05	9.52e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—APOE—multiple sclerosis	1.1e-05	9.47e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—BCHE—multiple sclerosis	1.1e-05	9.46e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.1e-05	9.44e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CXCR3—multiple sclerosis	1.09e-05	9.38e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CD28—multiple sclerosis	1.08e-05	9.3e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.07e-05	9.23e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.06e-05	9.15e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCR2—multiple sclerosis	1.06e-05	9.13e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.05e-05	9.04e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.05e-05	9.02e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.03e-05	8.85e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.02e-05	8.73e-05	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—MYC—multiple sclerosis	9.87e-06	8.49e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CNR1—multiple sclerosis	9.8e-06	8.42e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	9.8e-06	8.42e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.51e-06	8.18e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—POMC—multiple sclerosis	9.47e-06	8.14e-05	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—MYC—multiple sclerosis	9.43e-06	8.11e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	9.27e-06	7.97e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	9.27e-06	7.97e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—RRM1—multiple sclerosis	9.1e-06	7.82e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.06e-06	7.79e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—BCHE—multiple sclerosis	8.88e-06	7.63e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CXCL10—multiple sclerosis	8.82e-06	7.58e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.72e-06	7.5e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—BCHE—multiple sclerosis	8.69e-06	7.47e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—BCHE—multiple sclerosis	8.68e-06	7.46e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.67e-06	7.46e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—ALB—multiple sclerosis	8.63e-06	7.42e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GPC5—multiple sclerosis	8.47e-06	7.29e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—APOE—multiple sclerosis	8.31e-06	7.15e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.26e-06	7.1e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—BCHE—multiple sclerosis	8.2e-06	7.05e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—APOE—multiple sclerosis	8.01e-06	6.88e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.95e-06	6.83e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.78e-06	6.69e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CD86—multiple sclerosis	7.71e-06	6.63e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCL5—multiple sclerosis	7.59e-06	6.53e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—BCHE—multiple sclerosis	7.51e-06	6.46e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—APOE—multiple sclerosis	7.28e-06	6.26e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—APOE—multiple sclerosis	7.22e-06	6.21e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—POMC—multiple sclerosis	7.14e-06	6.14e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.1e-06	6.1e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.1e-06	6.1e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.06e-06	6.07e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SPP1—multiple sclerosis	7.03e-06	6.05e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—RRM1—multiple sclerosis	7.02e-06	6.04e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—POMC—multiple sclerosis	6.88e-06	5.91e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCR5—multiple sclerosis	6.84e-06	5.88e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL2RA—multiple sclerosis	6.74e-06	5.8e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—BCHE—multiple sclerosis	6.71e-06	5.77e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—APOE—multiple sclerosis	6.62e-06	5.69e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.59e-06	5.66e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—BCHE—multiple sclerosis	6.55e-06	5.63e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—ALB—multiple sclerosis	6.51e-06	5.6e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.47e-06	5.56e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—ALB—multiple sclerosis	6.27e-06	5.39e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—POMC—multiple sclerosis	6.26e-06	5.38e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—APOE—multiple sclerosis	6.22e-06	5.35e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—POMC—multiple sclerosis	6.2e-06	5.33e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—BCHE—multiple sclerosis	6.17e-06	5.3e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—BCHE—multiple sclerosis	6.12e-06	5.26e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.06e-06	5.21e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ALB—multiple sclerosis	5.7e-06	4.9e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—POMC—multiple sclerosis	5.69e-06	4.89e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ALB—multiple sclerosis	5.65e-06	4.86e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CD80—multiple sclerosis	5.63e-06	4.84e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.53e-06	4.75e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—POMC—multiple sclerosis	5.35e-06	4.6e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—APOE—multiple sclerosis	5.34e-06	4.59e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCL2—multiple sclerosis	5.23e-06	4.5e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—APOE—multiple sclerosis	5.23e-06	4.5e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—BCHE—multiple sclerosis	5.23e-06	4.49e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—APOE—multiple sclerosis	5.22e-06	4.49e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ALB—multiple sclerosis	5.18e-06	4.46e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—APOE—multiple sclerosis	4.93e-06	4.24e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MYC—multiple sclerosis	4.75e-06	4.09e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TYK2—multiple sclerosis	4.75e-06	4.08e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—POMC—multiple sclerosis	4.59e-06	3.94e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—APOE—multiple sclerosis	4.52e-06	3.89e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—POMC—multiple sclerosis	4.49e-06	3.86e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—POMC—multiple sclerosis	4.48e-06	3.85e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—POMC—multiple sclerosis	4.24e-06	3.64e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ALB—multiple sclerosis	4.18e-06	3.6e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ALB—multiple sclerosis	4.1e-06	3.52e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ALB—multiple sclerosis	4.09e-06	3.51e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—APOE—multiple sclerosis	4.03e-06	3.47e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—BCHE—multiple sclerosis	4.03e-06	3.47e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL2—multiple sclerosis	3.95e-06	3.4e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—APOE—multiple sclerosis	3.94e-06	3.39e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—POMC—multiple sclerosis	3.88e-06	3.34e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ALB—multiple sclerosis	3.86e-06	3.32e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MMP9—multiple sclerosis	3.74e-06	3.22e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—APOE—multiple sclerosis	3.71e-06	3.19e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—APOE—multiple sclerosis	3.68e-06	3.16e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ALB—multiple sclerosis	3.54e-06	3.04e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—POMC—multiple sclerosis	3.47e-06	2.98e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—POMC—multiple sclerosis	3.38e-06	2.91e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—STAT3—multiple sclerosis	3.33e-06	2.86e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—POMC—multiple sclerosis	3.19e-06	2.74e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—POMC—multiple sclerosis	3.16e-06	2.72e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ALB—multiple sclerosis	3.16e-06	2.72e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—APOE—multiple sclerosis	3.14e-06	2.7e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MYC—multiple sclerosis	3.09e-06	2.66e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ALB—multiple sclerosis	3.08e-06	2.65e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TGFB1—multiple sclerosis	3.08e-06	2.65e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MAPK1—multiple sclerosis	3.02e-06	2.6e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ALB—multiple sclerosis	2.91e-06	2.5e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ALB—multiple sclerosis	2.88e-06	2.48e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—POMC—multiple sclerosis	2.7e-06	2.32e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ALB—multiple sclerosis	2.46e-06	2.12e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APOE—multiple sclerosis	2.43e-06	2.09e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL6—multiple sclerosis	2.32e-06	2e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—POMC—multiple sclerosis	2.08e-06	1.79e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ALB—multiple sclerosis	1.9e-06	1.63e-05	CbGpPWpGaD
